VICKS SINEX

This brand name is authorized in Finland, Ireland, Netherlands, New Zealand, Poland, Romania, United Kingdom, South Africa

Active ingredients

The drug VICKS SINEX contains one active pharmaceutical ingredient (API):

1 Oxymetazoline UNII K89MJ0S5VY - OXYMETAZOLINE HYDROCHLORIDE

Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa. Read about Oxymetazoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AA05	Oxymetazoline	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 158663
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 88624, 88626
Country: NL	Z-Index G-Standaard	Identifier(s): 15010317, 15380270
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 6416
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17952, 17953
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100238796, 100418848, 100428723, 100428887, 100432239
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66384001, W66384002
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/16.1/0339